25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IKPM (Ikapharmindo) Stock Analysis
Buy, Hold or Sell?

Let's analyze Ikapharmindo together

I guess you are interested in Ikapharmindo Putramas Tbk.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Ikapharmindo’s Financial Insights
  • 📈 Technical Analysis (TA) – Ikapharmindo’s Price Targets

I'm going to help you getting a better view of Ikapharmindo Putramas Tbk.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Ikapharmindo Putramas Tbk.

I send you an email if I find something interesting about Ikapharmindo Putramas Tbk..

1. Quick Overview

1.1. Quick analysis of Ikapharmindo (30 sec.)










1.2. What can you expect buying and holding a share of Ikapharmindo? (30 sec.)

How much money do you get?

How much money do you get?
Rp14.78
When do you have the money?
1 year
How often do you get paid?
33.3%

What is your share worth?

Current worth
Rp2,399,796.62
Expected worth in 1 year
Rp2,454,913.70
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
Rp202,951.08
Return On Investment
100,470.8%

For what price can you sell your share?

Current Price per Share
Rp202.00
Expected price per share
Rp190.00 - Rp254.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ikapharmindo (5 min.)




Live pricePrice per Share (EOD)
Rp202.00
Rp2,399,796.62

2.2. Growth of Ikapharmindo (5 min.)




Is Ikapharmindo growing?

Current yearPrevious yearGrowGrow %
How rich?$404.2b$401.9b$2.3b0.6%

How much money is Ikapharmindo making?

Current yearPrevious yearGrowGrow %
Making money$8.2b$25.1b-$16.9b-205.8%
Net Profit Margin1.2%3.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Ikapharmindo (5 min.)




2.4. Comparing to competitors in the Pharmaceutical Retailers industry (5 min.)




  Industry Rankings (Pharmaceutical Retailers)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ikapharmindo?

Welcome investor! Ikapharmindo's management wants to use your money to grow the business. In return you get a share of Ikapharmindo.

First you should know what it really means to hold a share of Ikapharmindo. And how you can make/lose money.

Speculation

The Price per Share of Ikapharmindo is Rp202.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ikapharmindo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ikapharmindo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is Rp2,399,796.62. Based on the TTM, the Book Value Change Per Share is Rp13,779.27 per quarter. Based on the YOY, the Book Value Change Per Share is Rp663,151.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is Rp36,958.50 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ikapharmindo.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 Rp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per Share
Usd Eps4.892.4%4.892.4%14.957.4%12.005.9%12.005.9%12.005.9%
Usd Book Value Change Per Share1.380.7%1.380.7%66.3232.8%79.9939.6%79.9939.6%79.9939.6%
Usd Dividend Per Share3.701.8%3.701.8%0.000.0%1.230.6%1.230.6%1.230.6%
Usd Total Gains Per Share5.072.5%5.072.5%66.3232.8%81.2340.2%81.2340.2%81.2340.2%
Usd Price Per Share0.02-0.02-0.02-0.01-0.01-0.01-
Price to Earnings Ratio0.00-0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio0.00-0.00-0.00-0.00-0.00-0.00-
Price to Book Ratio0.00-0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio0.00-0.00-0.00-0.00-0.00-0.00-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0202
Number of shares49504
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share3.701.23
Usd Book Value Change Per Share1.3879.99
Usd Total Gains Per Share5.0781.23
Gains per Quarter (49504 shares)251,172.254,020,970.86
Gains per Year (49504 shares)1,004,689.0116,083,883.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
173183727285210046792439461583993816083873
2146367554570320093684878923167987532167756
3219551281855530140577318374751981348251639
42927350109140640187469757836335975064335522
536591871364258502343512197297919968880419405
643910251637109602812414636759503962696503288
75122862190996170328131707621110879563112587171
85854699218281380375021951566126719501128671054
96586537245566490421912195512142559439144754937
1073183742728516100468802439458158399376160838820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%3.00.00.0100.0%3.00.00.0100.0%3.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%3.00.00.0100.0%3.00.00.0100.0%3.00.00.0100.0%
Dividend per Share1.00.00.0100.0%1.00.02.033.3%1.00.02.033.3%1.00.02.033.3%1.00.02.033.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%3.00.00.0100.0%3.00.00.0100.0%3.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Ikapharmindo Putramas Tbk. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--13779.26913779.2690%663151.389-98%799932.208-98%799932.208-98%799932.208-98%
Book Value Per Share--2399796.6242399796.6240%2386017.355+1%2169559.982+11%2169559.982+11%2169559.982+11%
Current Ratio--1.5271.5270%1.570-3%1.496+2%1.496+2%1.496+2%
Debt To Asset Ratio--0.4990.4990%0.472+6%0.505-1%0.505-1%0.505-1%
Debt To Equity Ratio--0.9960.9960%0.894+12%1.028-3%1.028-3%1.028-3%
Dividend Per Share--36958.50036958.5000%-+100%12319.500+200%12319.500+200%12319.500+200%
Enterprise Value---3636685891869260.000-3636685891869260.0000%-2863890012754400.000-21%-3250287952311830.000-11%-3250287952311830.000-11%-3250287952311830.000-11%
Eps--48897.36748897.3670%149546.099-67%120026.473-59%120026.473-59%120026.473-59%
Ev To Sales Ratio---0.537-0.5370%-0.395-26%-0.466-13%-0.466-13%-0.466-13%
Free Cash Flow Per Share---364012.279-364012.2790%-187599.436-48%-187469.606-48%-187469.606-48%-187469.606-48%
Free Cash Flow To Equity Per Share---205964.360-205964.3600%319488.459-164%26610.238-874%26610.238-874%26610.238-874%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Market Cap340301313536.000-21%411057650000.000411057650000.0000%340301825000.000+21%250453158333.333+64%250453158333.333+64%250453158333.333+64%
Net Profit Margin--0.0120.0120%0.035-65%0.030-59%0.030-59%0.030-59%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio--0.5470.5470%0.571-4%0.554-1%0.554-1%0.554-1%
Pb Ratio0.000-21%0.0000.0000%0.000+20%0.000+64%0.000+64%0.000+64%
Pe Ratio0.004-21%0.0050.0050%0.001+269%0.002+136%0.002+136%0.002+136%
Price Per Share202.000-21%244.000244.0000%202.000+21%148.667+64%148.667+64%148.667+64%
Price To Free Cash Flow Ratio-0.001+17%-0.001-0.0010%-0.001+61%-0.001-13%-0.001-13%-0.001-13%
Price To Total Gains Ratio0.004-21%0.0050.0050%0.000+1479%0.003+88%0.003+88%0.003+88%
Quick Ratio--1.2691.2690%1.247+2%1.152+10%1.152+10%1.152+10%
Return On Assets--0.0100.0100%0.033-69%0.029-64%0.029-64%0.029-64%
Return On Equity--0.0200.0200%0.063-67%0.059-65%0.059-65%0.059-65%
Total Gains Per Share--50737.76950737.7690%663151.389-92%812251.708-94%812251.708-94%812251.708-94%
Usd Book Value--404284738039.268404284738039.2680%401963396221.606+1%365497634291.503+11%365497634291.503+11%365497634291.503+11%
Usd Book Value Change Per Share--1.3781.3780%66.315-98%79.993-98%79.993-98%79.993-98%
Usd Book Value Per Share--239.980239.9800%238.602+1%216.956+11%216.956+11%216.956+11%
Usd Dividend Per Share--3.6963.6960%-+100%1.232+200%1.232+200%1.232+200%
Usd Enterprise Value---363668589186.926-363668589186.9260%-286389001275.440-21%-325028795231.183-11%-325028795231.183-11%-325028795231.183-11%
Usd Eps--4.8904.8900%14.955-67%12.003-59%12.003-59%12.003-59%
Usd Free Cash Flow---61323783525.714-61323783525.7140%-31604173433.274-48%-31582301502.481-48%-31582301502.481-48%-31582301502.481-48%
Usd Free Cash Flow Per Share---36.401-36.4010%-18.760-48%-18.747-48%-18.747-48%-18.747-48%
Usd Free Cash Flow To Equity Per Share---20.596-20.5960%31.949-164%2.661-874%2.661-874%2.661-874%
Usd Market Cap34030131.354-21%41105765.00041105765.0000%34030182.500+21%25045315.833+64%25045315.833+64%25045315.833+64%
Usd Price Per Share0.020-21%0.0240.0240%0.020+21%0.015+64%0.015+64%0.015+64%
Usd Profit--8237556081.5528237556081.5520%25193470536.864-67%20220409728.702-59%20220409728.702-59%20220409728.702-59%
Usd Revenue--676865002103.994676865002103.9940%724611562595.094-7%685479319584.489-1%685479319584.489-1%685479319584.489-1%
Usd Total Gains Per Share--5.0745.0740%66.315-92%81.225-94%81.225-94%81.225-94%
 EOD+3 -5MRQTTM+0 -0YOY+11 -263Y+15 -225Y+15 -2210Y+15 -22

3.3 Fundamental Score

Let's check the fundamental score of Ikapharmindo Putramas Tbk. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.004
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than00.012
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.269
Current Ratio (MRQ)Greater than11.527
Debt to Asset Ratio (MRQ)Less than10.499
Debt to Equity Ratio (MRQ)Less than10.996
Return on Equity (MRQ)Greater than0.150.020
Return on Assets (MRQ)Greater than0.050.010
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Ikapharmindo Putramas Tbk. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose206.000
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Ikapharmindo Putramas Tbk.

PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and nutraceuticals; and over-the-counter drugs. It also provides consumer health products, cosmetics, hair care products, and baby care products. PT Ikapharmindo Putramas Tbk was founded in 1978 and is headquartered in Jakarta Timur, Indonesia. PT Ikapharmindo Putramas Tbk is a subsidiary of PT Ikapharma Inti Mas.

Fundamental data was last updated by Penke on 2025-08-22 06:31:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Ikapharmindo earns for each Rp1 of revenue.

  • Above 10% is considered healthy but always compare Ikapharmindo to the Pharmaceutical Retailers industry mean.
  • A Net Profit Margin of 1.2% means that Rp0.01 for each Rp1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ikapharmindo Putramas Tbk.:

  • The MRQ is 1.2%. The company is making a profit. +1
  • The TTM is 1.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.2%0.0%
TTM1.2%YOY3.5%-2.3%
TTM1.2%5Y3.0%-1.7%
5Y3.0%10Y3.0%0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%1.3%-0.1%
TTM1.2%1.2%+0.0%
YOY3.5%1.3%+2.2%
3Y3.0%1.4%+1.6%
5Y3.0%1.8%+1.2%
10Y3.0%1.4%+1.6%
4.3.1.2. Return on Assets

Shows how efficient Ikapharmindo is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ikapharmindo to the Pharmaceutical Retailers industry mean.
  • 1.0% Return on Assets means that Ikapharmindo generated Rp0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ikapharmindo Putramas Tbk.:

  • The MRQ is 1.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.0%TTM1.0%0.0%
TTM1.0%YOY3.3%-2.3%
TTM1.0%5Y2.9%-1.8%
5Y2.9%10Y2.9%0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0%0.4%+0.6%
TTM1.0%0.5%+0.5%
YOY3.3%0.5%+2.8%
3Y2.9%0.7%+2.2%
5Y2.9%0.8%+2.1%
10Y2.9%0.7%+2.2%
4.3.1.3. Return on Equity

Shows how efficient Ikapharmindo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ikapharmindo to the Pharmaceutical Retailers industry mean.
  • 2.0% Return on Equity means Ikapharmindo generated Rp0.02 for each Rp1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ikapharmindo Putramas Tbk.:

  • The MRQ is 2.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.0%0.0%
TTM2.0%YOY6.3%-4.2%
TTM2.0%5Y5.9%-3.9%
5Y5.9%10Y5.9%0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0%1.5%+0.5%
TTM2.0%2.1%-0.1%
YOY6.3%2.1%+4.2%
3Y5.9%2.9%+3.0%
5Y5.9%3.0%+2.9%
10Y5.9%2.4%+3.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Ikapharmindo Putramas Tbk..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Ikapharmindo is operating .

  • Measures how much profit Ikapharmindo makes for each Rp1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ikapharmindo to the Pharmaceutical Retailers industry mean.
  • An Operating Margin of 0.0% means the company generated Rp0.00  for each Rp1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ikapharmindo Putramas Tbk.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2%-0.2%
TTM-0.6%-0.6%
YOY-1.4%-1.4%
3Y-1.4%-1.4%
5Y-2.5%-2.5%
10Y-2.3%-2.3%
4.3.2.2. Operating Ratio

Measures how efficient Ikapharmindo is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • An Operation Ratio of 0.55 means that the operating costs are Rp0.55 for each Rp1 in net sales.

Let's take a look of the Operating Ratio trends of Ikapharmindo Putramas Tbk.:

  • The MRQ is 0.547. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.547. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.547TTM0.5470.000
TTM0.547YOY0.571-0.024
TTM0.5475Y0.554-0.007
5Y0.55410Y0.5540.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5471.180-0.633
TTM0.5471.237-0.690
YOY0.5711.020-0.449
3Y0.5541.164-0.610
5Y0.5541.127-0.573
10Y0.5541.155-0.601
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Ikapharmindo Putramas Tbk..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ikapharmindo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A Current Ratio of 1.53 means the company has Rp1.53 in assets for each Rp1 in short-term debts.

Let's take a look of the Current Ratio trends of Ikapharmindo Putramas Tbk.:

  • The MRQ is 1.527. The company is able to pay all its short-term debts. +1
  • The TTM is 1.527. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.527TTM1.5270.000
TTM1.527YOY1.570-0.043
TTM1.5275Y1.496+0.032
5Y1.49610Y1.4960.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5271.321+0.206
TTM1.5271.318+0.209
YOY1.5701.270+0.300
3Y1.4961.305+0.191
5Y1.4961.338+0.158
10Y1.4961.497-0.001
4.4.3.2. Quick Ratio

Measures if Ikapharmindo is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ikapharmindo to the Pharmaceutical Retailers industry mean.
  • A Quick Ratio of 1.27 means the company can pay off Rp1.27 for each Rp1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ikapharmindo Putramas Tbk.:

  • The MRQ is 1.269. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.269. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.269TTM1.2690.000
TTM1.269YOY1.247+0.022
TTM1.2695Y1.152+0.117
5Y1.15210Y1.1520.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2690.490+0.779
TTM1.2690.483+0.786
YOY1.2470.623+0.624
3Y1.1520.577+0.575
5Y1.1520.634+0.518
10Y1.1520.824+0.328
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Ikapharmindo Putramas Tbk..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Ikapharmindo assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ikapharmindo to Pharmaceutical Retailers industry mean.
  • A Debt to Asset Ratio of 0.50 means that Ikapharmindo assets are financed with 49.9% credit (debt) and the remaining percentage (100% - 49.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ikapharmindo Putramas Tbk.:

  • The MRQ is 0.499. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.499. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.499TTM0.4990.000
TTM0.499YOY0.472+0.027
TTM0.4995Y0.505-0.006
5Y0.50510Y0.5050.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4990.644-0.145
TTM0.4990.643-0.144
YOY0.4720.643-0.171
3Y0.5050.653-0.148
5Y0.5050.622-0.117
10Y0.5050.597-0.092
4.5.4.2. Debt to Equity Ratio

Measures if Ikapharmindo is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ikapharmindo to the Pharmaceutical Retailers industry mean.
  • A Debt to Equity ratio of 99.6% means that company has Rp1.00 debt for each Rp1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ikapharmindo Putramas Tbk.:

  • The MRQ is 0.996. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.996. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.996TTM0.9960.000
TTM0.996YOY0.894+0.103
TTM0.9965Y1.028-0.031
5Y1.02810Y1.0280.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9961.294-0.298
TTM0.9961.463-0.467
YOY0.8941.745-0.851
3Y1.0281.908-0.880
5Y1.0281.732-0.704
10Y1.0281.637-0.609
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every Rp1 in earnings Ikapharmindo generates.

  • Above 15 is considered overpriced but always compare Ikapharmindo to the Pharmaceutical Retailers industry mean.
  • A PE ratio of 0.00 means the investor is paying Rp0.00 for every Rp1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ikapharmindo Putramas Tbk.:

  • The EOD is 0.004. Based on the earnings, the company is cheap. +2
  • The MRQ is 0.005. Based on the earnings, the company is cheap. +2
  • The TTM is 0.005. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.004MRQ0.005-0.001
MRQ0.005TTM0.0050.000
TTM0.005YOY0.001+0.004
TTM0.0055Y0.002+0.003
5Y0.00210Y0.0020.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD0.00415.377-15.373
MRQ0.00514.691-14.686
TTM0.00514.691-14.686
YOY0.00117.962-17.961
3Y0.00217.796-17.794
5Y0.00223.407-23.405
10Y0.00228.851-28.849
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ikapharmindo Putramas Tbk.:

  • The EOD is -0.001. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.001. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.001. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.001MRQ-0.001+0.000
MRQ-0.001TTM-0.0010.000
TTM-0.001YOY-0.001+0.000
TTM-0.0015Y-0.0010.000
5Y-0.00110Y-0.0010.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0017.709-7.710
MRQ-0.0017.482-7.483
TTM-0.0012.832-2.833
YOY-0.0016.697-6.698
3Y-0.0014.593-4.594
5Y-0.0015.464-5.465
10Y-0.0018.456-8.457
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Ikapharmindo is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A PB ratio of 0.00 means the investor is paying Rp0.00 for each Rp1 in book value.

Let's take a look of the Price to Book Ratio trends of Ikapharmindo Putramas Tbk.:

  • The EOD is 0.000. Based on the equity, the company is cheap. +2
  • The MRQ is 0.000. Based on the equity, the company is cheap. +2
  • The TTM is 0.000. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.0000.000
MRQ0.000TTM0.0000.000
TTM0.000YOY0.000+0.000
TTM0.0005Y0.000+0.000
5Y0.00010Y0.0000.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD0.0001.434-1.434
MRQ0.0001.731-1.731
TTM0.0001.731-1.731
YOY0.0001.501-1.501
3Y0.0001.632-1.632
5Y0.0002.149-2.149
10Y0.0003.083-3.083
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets491,378,023
Total Liabilities245,253,137
Total Stockholder Equity246,124,886
 As reported
Total Liabilities 245,253,137
Total Stockholder Equity+ 246,124,886
Total Assets = 491,378,023

Assets

Total Assets491,378,023
Total Current Assets337,203,713
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 23,829,970
Net Receivables 256,357,709
Inventory 51,762,920
Total Current Assets  (as reported)337,203,713
Total Current Assets  (calculated)331,950,598
+/- 5,253,115
Long-term Assets
Property Plant Equipment 108,923,363
Intangible Assets 14,573,459
Long-term Assets  (as reported)0
Long-term Assets  (calculated)123,496,822
+/- 123,496,822

Liabilities & Shareholders' Equity

Total Current Liabilities220,756,404
Long-term Liabilities0
Total Stockholder Equity246,124,886
Total Current Liabilities
Short-term Debt 170,988,866
Total Current Liabilities  (as reported)220,756,404
Total Current Liabilities  (calculated)170,988,866
+/- 49,767,538
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock168,466,250
Retained Earnings 45,587,161
Capital Surplus 19,089,053
Other Stockholders Equity 12,982,422
Total Stockholder Equity (as reported)246,124,886
Total Stockholder Equity (calculated)246,124,886
+/-0
Other
Cash and Short Term Investments 23,829,970
Common Stock Shares Outstanding 1,684,663
Liabilities and Stockholders Equity 491,378,023
Net Working Capital 116,447,309



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-31
> Total Assets 
387,553,016
463,376,975
491,378,023
491,378,023463,376,975387,553,016
   > Total Current Assets 
268,799,494
308,084,023
337,203,713
337,203,713308,084,023268,799,494
       Cash And Cash Equivalents 
10,883,117
44,293,554
23,829,970
23,829,97044,293,55410,883,117
       Net Receivables 
170,734,675
200,363,702
256,357,709
256,357,709200,363,702170,734,675
       Inventory 
79,284,049
56,009,407
51,762,920
51,762,92056,009,40779,284,049
   > Long-term Assets 000
       Property Plant Equipment 
78,214,494
113,502,223
108,923,363
108,923,363113,502,22378,214,494
       Intangible Assets 
14,274,754
14,353,841
14,573,459
14,573,45914,353,84114,274,754
> Total Liabilities 
210,854,630
218,665,301
245,253,137
245,253,137218,665,301210,854,630
   > Total Current Liabilities 
193,455,678
196,174,263
220,756,404
220,756,404196,174,263193,455,678
       Short-term Debt 
143,808,720
149,400,300
170,988,866
170,988,866149,400,300143,808,720
   > Long-term Liabilities 000
> Total Stockholder Equity
176,698,386
244,711,674
246,124,886
246,124,886244,711,674176,698,386
   Common Stock
100,000,000
168,466,250
168,466,250
168,466,250168,466,250100,000,000
   Retained Earnings 
63,798,146
44,362,702
45,587,161
45,587,16144,362,70263,798,146
   Capital Surplus 
350,000
19,089,053
19,089,053
19,089,05319,089,053350,000
   Treasury Stock000
   Other Stockholders Equity 
12,550,240
12,793,669
12,982,422
12,982,42212,793,66912,550,240



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue412,069,282
Cost of Revenue-225,382,362
Gross Profit186,686,920186,686,920
 
Operating Income (+$)
Gross Profit186,686,920
Operating Expense-0
Operating Income18,783,530186,686,920
 
Operating Expense (+$)
Research Development0
Selling General Administrative167,175,906
Selling And Marketing Expenses0
Operating Expense0167,175,906
 
Net Interest Income (+$)
Interest Income10,748,892
Interest Expense-684,617
Other Finance Cost-10,064,275
Net Interest Income0
 
Pretax Income (+$)
Operating Income18,783,530
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)8,034,63818,783,530
EBIT - interestExpense = -684,617
5,014,950
5,699,566
Interest Expense684,617
Earnings Before Interest and Taxes (EBIT)08,719,255
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax8,034,638
Tax Provision-3,019,688
Net Income From Continuing Ops05,014,950
Net Income5,014,950
Net Income Applicable To Common Shares5,014,950
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of Ikapharmindo
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ikapharmindo. The general trend of Ikapharmindo is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ikapharmindo's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Ikapharmindo Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ikapharmindo Putramas Tbk..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 244.00 < 244.00 < 254.00.

The bearish price targets are: 192.00 > 192.00 > 190.00.

Know someone who trades $IKPM? Share this with them.👇

Ikapharmindo Putramas Tbk. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ikapharmindo Putramas Tbk.. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ikapharmindo Putramas Tbk. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily Moving Average Convergence/Divergence (MACD) ChartIkapharmindo Putramas Tbk. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ikapharmindo Putramas Tbk.. The current adx is .

Ikapharmindo Putramas Tbk. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily Relative Strength Index (RSI) ChartIkapharmindo Putramas Tbk. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily Stochastic Oscillator ChartIkapharmindo Putramas Tbk. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily Commodity Channel Index (CCI) ChartIkapharmindo Putramas Tbk. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily Chande Momentum Oscillator (CMO) ChartIkapharmindo Putramas Tbk. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily Williams %R ChartIkapharmindo Putramas Tbk. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily Average True Range (ATR) ChartIkapharmindo Putramas Tbk. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily On-Balance Volume (OBV) ChartIkapharmindo Putramas Tbk. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. Daily Money Flow Index (MFI) ChartIkapharmindo Putramas Tbk. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ikapharmindo Putramas Tbk..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-09-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-09-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Ikapharmindo Putramas Tbk. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ikapharmindo Putramas Tbk. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose206.000
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ikapharmindo with someone you think should read this too:
  • Are you bullish or bearish on Ikapharmindo? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ikapharmindo? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ikapharmindo Putramas Tbk.

I send you an email if I find something interesting about Ikapharmindo Putramas Tbk..


Comments

How you think about this?

Leave a comment

Stay informed about Ikapharmindo Putramas Tbk..

Receive notifications about Ikapharmindo Putramas Tbk. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.